Vaill A - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes.

Tada T, Dcosta BM, Samanovic MI, Herati RS, Cornelius A, Zhou H, Vaill A, Kazmierski W, Mulligan MJ, Landau NR. Tada T, et al. Among authors: vaill a. mBio. 2021 Jun 29;12(3):e0069621. doi: 10.1128/mBio.00696-21. Epub 2021 Jun 1. mBio. 2021. PMID: 34060334 Free PMC article.

Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies.

Tada T, Dcosta BM, Zhou H, Vaill A, Kazmierski W, Landau NR. Tada T, et al. Among authors: vaill a. bioRxiv [Preprint]. 2021 Feb 19:2021.02.18.431897. doi: 10.1101/2021.02.18.431897. bioRxiv. 2021. PMID: 33619484 Free PMC article. Preprint.

Use of micro-emulsion technology for the directed evolution of antibodies.

Buhr DL, Acca FE, Holland EG, Johnson K, Maksymiuk GM, Vaill A, Kay BK, Weitz DA, Weiner MP, Kiss MM. Buhr DL, et al. Among authors: vaill a. Methods. 2012 Sep;58(1):28-33. doi: 10.1016/j.ymeth.2012.07.007. Epub 2012 Jul 20. Methods. 2012. PMID: 22819852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters